Clinical pharmacogenomics in action: design, assessment and implementation of a novel pharmacogenetic panel supporting drug selection for diseases of the central nervous system (CNS)

Bothos E, Ntoumou E, Kelaidoni K, Roukas D, Drakoulis N, Papasavva M, Karakostis FA, Moulos P, Karakostis K

Cost-Effectiveness Analysis of Pharmacogenetic-Guided Treatment in Drug Resistant Depression

Chatziandreou E and Panagiotou N

iDNA PGx CNS improves MDD treatment decisions and clinical outcomes: A patient case series analysis

Gkouvas N, Gkikas P, Ntoumou E, Manthos P, Panagiotou N, Bersimis F

iDNA PGx CNS: Pharmacogenetics-Empowered Precision Medicine Improves Treatment Outcomes in Major Depressive Disorder

Panagiotou N, Ntoumou E, Sagonas A, Salata E, Fotis A, Roukas D, Chatziandreou E